The First Affiliated Hospital of China Medical University
The First Affiliated Hospital of China Medical University
Shenyang, Liaoning, China12 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Study of Cizutamig in Thyroid Eye Disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Graves Ophthalmopathy, Graves disease, autoimmune disease, disease of orbital part of eye adnexa, endocrine system disorder, exophthalmos, eye disorder, goiter, hereditary disease, hyperthyroidism, immune system disorder, thyroid gland disorder | Recruiting | Phase 1 | 2026-09-01 | NCT07597200 | |
| A Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of Plonmarlimab in Subjects With Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis (Also Known as Macrophage Activation Syndrome [MAS]) | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence | Recruiting | Phase 3 | 2026-07-20 | NCT07208058 | |
| RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Small Cell Lung Cancer (sqNSCLC) | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 3 | 2026-07-14 | NCT07416474 | |
| SPH5030 Tablets in Subjects With Advanced Her2-positive Solid Tumors | HER2-positive Advanced Solid Tumors | Recruiting | Early phase 1 | 2026-05-05 | NCT05245058 | |
| A Multicentre, Randomised, Double-blind, Positive-control Clinical Trial Evaluating Dihydroartemisinin Tablets for the Treatment of Discoid Lupus Erythematosus | Skin and Connective Tissue Diseases, connective tissue disorder, cutaneous lupus erythematosus, discoid lupus erythematosus, skin disorder | Not yet recruiting | Phase 2 | 2026-04-30 | NCT07557927 | |
| Study on the Pathogenesis and Reversal Strategies of Cancer Cachexia Based on Multi-Omics | Atrophy, Body Weight, Body Weight Changes, Cachexia, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, Thinness, Weight Loss, muscular atrophy, neoplasm, nervous system disorder | Recruiting | Not applicable | 2026-04-09 | NCT07519837 | |
| Comparison of Radiofrequency Ablation With Concomitant or Staged Treatment for Tributary Varicose Veins | Varicose Veins of Lower Limb | Not yet recruiting | Not applicable | 2026-03-03 | NCT07445425 | |
| A Study of GFH375 in Patients With Advanced Solid Tumors With KRAS G12D Mutations | Advanced Solid Tumors; KRAS G12D Mutations | Recruiting | Phase 1 / Phase 2 | 2025-11-20 | NCT06500676 | |
| A Phase III Clinical Study of H077 Sustained-Release Tablets Compared With Silodosin Capsules in the Treatment of Benign Prostatic Hyperplasia | Genital Diseases, Lower Urinary Tract Symptoms, Male Urogenital Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, Urological Manifestations, benign prostatic hyperplasia, male reproductive system disorder, prostate disorder | Not yet recruiting | Phase 3 | 2025-08-28 | NCT07146386 | |
| The Study About the Identification of Treatable Traits of Severe Asthma and the Construction of Personalized Treatment System | Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Not applicable | 2025-08-22 | NCT07136025 | |
| Long-term Impact of Inhaled Tobramycin for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE II) | Bacterial Infections and Mycoses, Infections, Pseudomonas infection, bacterial infectious disease, bronchial disorder, bronchiectasis, gram-negative bacterial infections, respiratory system disorder | Recruiting | Not stated | 2025-04-01 | NCT06760273 | |
| Study of MCLA-129 in the Treatment of Advanced Non-small Cell Lung Cancer with AGA and MET Amplification. | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Phase 2 | 2025-03-20 | NCT06885840 |